Metallomics · 2019 · 131 citations · 21 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyCancer ImmunotherapyColorectal CancerDeath ReceptorsApoptosis Signaling In CancerCancer Cell ApoptosisCell Death In CancerChemotherapy-induced Immunogenic Cell DeathImmune System DisruptionImmunogenic Cell Death InductionMetal-based TherapeuticsOxaliplatin-based Therapy
The ruthenium complex sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339/IT-139) showed preclinical activity in a variety of in vivo tumor models including a highly predictive colon cancer model. The compound has entered clinical trials, where patients experienced disease stabilization accompanied by mild side effects. KP1339, a GRP78 inhibitor, disrupts endoplasmic reticulum (ER) homeostasis leading to cell death. The PERK/eIF2α-branch of the ER plays an essential role in the cascade of events triggering immunogenic cell death (ICD). ICD makes dying cancer cells 'visible' to the immune system, initiating a prolonged immune response against the tumor. As some metal-based chemotherapeutics such as oxaliplatin are able to induce ICD, we investigate whether KP1339 could also trigger induction of the ICD signature. For this, we employ a three-dimensional colon cancer spheroid model and show for the first time that the treatment with KP1339, a ruthenium-based complex, triggers an ICD signature hallmarked by phosphorylation of PERK and eIF2α, exposure of calreticulin on the cell membrane, release of high mobility group box 1 and secretion of ATP.
21
Immunogenic death of colon cancer cells treated with oxaliplatin
Antoine Tesnière, F. Schlemmer, Valérie Boige et al. · Oncogene · 2009 · 1.1K citations
Medicine, Oncology, Pharmacology +14
Molecular mechanisms of ATP secretion during immunogenic cell death
Isabel Martins, Yan Wang, Michael Michaud et al. · Cell Death and Differentiation · 2013 · 537 citations
Autophagic degradation of active caspase-8
Wen‐Chi Hou, Jie Han, Caisheng Lu et al. · Autophagy · 2010 · 344 citations · Full text
Abhishek D. Garg, Dmitri V. Krysko, Peter Vandenabeele et al. · Cancer Immunology Immunotherapy · 2011 · 284 citations · Full text